CDH1 and glioblastoma: In addition, CDH1 mRNA levels did not significantly change in most of the tested non-epithelial cancers (including lymphoid neoplasm diffuse large B-cell lymphoma, glioblastoma multiforme, acute myeloid leukemia, brain lower-grade glioma, mesothelioma, pheochromocytoma and paraganglioma, sarcoma, and uveal melanoma) compared to corresponding normal tissues (Fig. 3C).